US2011118433A1PendingUtilityA1
Candida tropicalis cells and use thereof
Est. expiryNov 11, 2029(~3.3 yrs left)· nominal 20-yr term from priority
C12Y 101/01001C12N 1/16C12P 13/04C07C 67/42C12P 7/62C07C 227/06C12P 7/625C12N 9/004C07C 51/347C12N 9/0042C07C 227/08C12P 7/42
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to genetically engineered Candida tropicalis cells, use thereof and a method of production of ω-hydroxycarboxylic acids and ω-hydroxycarboxylic acid esters.
Claims
exact text as granted — not AI-modified1 . A mutant Candida tropicalis cell, which has, compared with a wild type Candida tropicalis cell, a reduced activity of at least one of enzyme that is encoded by an intron-free nucleic acid sequence selected from groups A) and B)
A) Seq ID No. 1, Seq ID No. 3, Seq ID No. 5, Seq ID No. 7, Seq ID No. 9, Seq ID No. 11, Seq ID No. 13, Seq ID No. 15, Seq ID No. 17, Seq ID No. 19, Seq ID No. 21, Seq ID No. 23, Seq ID No. 25, Seq ID No. 27, Seq ID No. 29, Seq ID No. 31, Seq ID No. 33, Seq ID No. 35, Seq ID No. 37, Seq ID No. 39, Seq ID No. 41, Seq ID No. 43, Seq ID No. 45, Seq ID No. 47, Seq ID No. 49, Seq ID No. 51, Seq ID No. 53, Seq ID No. 55, Seq ID No. 57, Seq ID No. 59, Seq ID No. 61, Seq ID No. 63, Seq ID No. 65 and Seq ID No. 67 B) a sequence that is 80% identical to at least to one sequence selected from the group consisting of Seq ID No. 1, Seq ID No. 3, Seq ID No. 5, Seq ID No. 7, Seq ID No. 9, Seq ID No. 11, Seq ID No. 13, Seq ID No. 15, Seq ID No. 17, Seq ID No. 19, Seq ID No. 21, Seq ID No. 23, Seq ID No. 25, Seq ID No. 27, Seq ID No. 29, Seq ID No. 31, Seq ID No. 33, Seq ID No. 35, Seq ID No. 37, Seq ID No. 39, Seq ID No. 41, Seq ID No. 43, Seq ID No. 45, Seq ID No. 47, Seq ID No. 49, Seq ID No. 51, Seq ID No. 53, Seq ID No. 55, Seq ID No. 57, Seq ID No. 59, Seq ID No. 61, Seq ID No. 63, Seq ID No. 65 and Seq ID No. 67.
2 . The Candida tropicalis cell according to claim 1 , wherein the decrease in enzymatic activity is achieved by modification of the nucleic acid sequence in the cell, wherein the modification is selected from the group consisting of insertion of foreign DNA into the nucleic acid sequence in the cell, deletion of at least parts of the nucleic acid sequence in the cell, a point mutation in the nucleic acid sequence in the cell, subjecting the nucleic acid sequence in the cell to RNA interference and exchanging a part of the nucleic acid sequence in the cell with foreign DNA.
3 . The Candida tropicalis cell according to claim 2 , wherein the foreign DNA is a selection marker gene.
4 . The Candida tropicalis cell according to claim 1 , wherein the cell is blocked at least partially in its β-oxidation.
5 . The Candida tropicalis cell according to claim 1 , which is derived from a strain selected from the group consisting of Candida tropicalis H41, Candida tropicalis H41B, Candida tropicalis H51, Candida tropicalis H45, Candida tropicalis H43, Candida tropicalis H53, Candida tropicalis H534, Candida tropicalis 534B, Candida tropicalis H435, Candida tropicalis ATCC20962 and Candida tropicalis HDC100.
6 . The Candida tropicalis cell according to claim 5 , which is derived from Candida tropicalis ATCC20962 or Candida tropicalis HDC100.
7 . A method for producing ω-hydroxycarboxylic acid or ω-hydroxycarboxylic acid ester, the method comprising
a) contacting the Candida tropicalis cell according to claim 1 with a medium comprising a carboxylic acid or a carboxylic acid ester,
b) cultivating the cell under conditions to form the corresponding ω-hydroxycarboxylic acid or ω-hydroxycarboxylic acid esters from the carboxylic acid or the carboxylic acid ester and
c) optionally isolating the ω-hydroxycarboxylic acid or ω-hydroxycarboxylic acid esters that formed.
8 . A method of producing a C. tropicalis cell according to claim 1 , the method comprising:
I) preparing a C. tropicalis cell and II) modifying at least one gene comprising one of the sequences selected from the nucleic acid sequence groups A) and B) stated in claim 1 by insertion of foreign DNA into the gene, deletion at least of a part of the gene, a point mutation in the gene sequence, subjecting the gene to RNA interference and exchanging a part of the gene with foreign DNA.
9 . The method according to claim 7 , wherein the ω-hydroxycarboxylic acid or ω-hydroxycarboxylic acid ester is a ω-hydroxycarboxylic acid or ω-hydroxycarboxylic acid ester with a chain length of the carboxylic acid from 6 to 24 carbon atoms and a chain length of the alcohol component of the ester from 1 to 4 carbon atoms
10 . The method according to claim 7 , wherein the ω-hydroxycarboxylic acid or ω-hydroxycarboxylic acid ester is a 12-hydroxydodecanoic acid or 12-hydroxydodecanoic acid methyl ester.
11 . A method according to claim 7 , wherein the Candida tropicalis cells are derived from a strain selected from the group consisting of Candida tropicalis H41, Candida tropicalis H41B, Candida tropicalis H51, Candida tropicalis H45, Candida tropicalis H43, Candida tropicalis H53, Candida tropicalis H534, Candida tropicalis 534B, Candida tropicalis H435, Candida tropicalis ATCC20962 and Candida tropicalis HDC100 and wherein the cells are at least partially blocked in their β-oxidation.
12 . A method of manufacturing a polymer, the method comprising polymerizing the ω-hydroxycarboxylic acid or of the ω-hydroxycarboxylic acid ester obtained by the method according to claim 7 .Join the waitlist — get patent alerts
Track US2011118433A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.